{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:14:26Z","timestamp":1790252066526,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Retina"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.oret.2024.12.006","type":"journal-article","created":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T01:04:44Z","timestamp":1733447084000},"page":"505-514","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Influence of Common Medications on Diabetic Macular Edema in Type 2 Diabetes Mellitus"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-2830-9832","authenticated-orcid":false,"given":"Jawad","family":"Muayad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2136-4650","authenticated-orcid":false,"given":"Asad","family":"Loya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3436-2651","authenticated-orcid":false,"given":"Zain S.","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5870-134X","authenticated-orcid":false,"given":"Debora H.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9735-7089","authenticated-orcid":false,"given":"Muhammad Z.","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew G.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5759-6579","authenticated-orcid":false,"given":"Asadolah","family":"Movahedan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami S.","family":"Dahr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.oret.2024.12.006_bib1","series-title":"National Diabetes Statistics Report","year":"2024"},{"issue":"6","key":"10.1016\/j.oret.2024.12.006_bib2","doi-asserted-by":"crossref","first-page":"98","DOI":"10.4239\/wjd.v2.i6.98","article-title":"Managing diabetic macular edema: the leading cause of diabetes blindness","volume":"2","author":"Romero-Aroca","year":"2011","journal-title":"World J Diabetes"},{"issue":"4","key":"10.1016\/j.oret.2024.12.006_bib3","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1001\/jamaophthalmol.2022.0052","article-title":"Trends in prevalence and treatment of diabetic macular edema and vision-threatening diabetic retinopathy among medicare part B fee-for-service beneficiaries","volume":"140","author":"Lundeen","year":"2022","journal-title":"JAMA Ophthalmol"},{"issue":"7","key":"10.1016\/j.oret.2024.12.006_bib4","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.ophtha.2015.03.024","article-title":"Diabetic macular edema: pathophysiology and novel therapeutic targets","volume":"122","author":"Das","year":"2015","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.oret.2024.12.006_bib5","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.3390\/cells11121950","article-title":"Current and novel therapeutic approaches for treatment of diabetic macular edema","volume":"11","author":"Chauhan","year":"2022","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.oret.2024.12.006_bib6","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.ophtha.2010.02.031","article-title":"Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema","volume":"117","author":"Diabetic Retinopathy Clinical Research Network","year":"2010","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.oret.2024.12.006_bib7","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.ophtha.2009.01.011","article-title":"Randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus macular photocoagulation in diabetic macular edema","volume":"116","author":"Soheilian","year":"2009","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.oret.2024.12.006_bib8","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1177\/1120672119857511","article-title":"First-line treatment algorithm and guidelines in center-involving diabetic macular edema","volume":"29","author":"Kodjikian","year":"2019","journal-title":"Eur J Ophthalmol"},{"issue":"9","key":"10.1016\/j.oret.2024.12.006_bib9","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s11892-019-1188-4","article-title":"Treatment of diabetic macular edema","volume":"19","author":"Kim","year":"2019","journal-title":"Curr Diab Rep"},{"issue":"12","key":"10.1016\/j.oret.2024.12.006_bib10","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1007\/s00592-019-01416-4","article-title":"Real-world outcomes of non-responding diabetic macular edema treated with continued anti-VEGF therapy versus early switch to dexamethasone implant: 2-year results","volume":"56","author":"Busch","year":"2019","journal-title":"Acta Diabetol"},{"issue":"11","key":"10.1016\/j.oret.2024.12.006_bib11","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1016\/j.ophtha.2016.07.010","article-title":"Optical coherence tomography angiography of DME and its association with anti-VEGF treatment response","volume":"123","author":"Lee","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2024.12.006_bib12","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.biopha.2018.08.088","article-title":"Recent updates on GLP-1 agonists: current advancements and challenges","volume":"108","author":"Sharma","year":"2018","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"10.1016\/j.oret.2024.12.006_bib13","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12916-019-1373-y","article-title":"The comorbidity burden of type 2 diabetes mellitus: patterns, clusters and predictions from a large English primary care cohort","volume":"17","author":"Nowakowska","year":"2019","journal-title":"BMC Med"},{"issue":"6","key":"10.1016\/j.oret.2024.12.006_bib14","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.survophthal.2023.07.002","article-title":"GLP-1 receptor agonists and diabetic retinopathy: a meta-analysis of randomized clinical trials","volume":"68","author":"Kapoor","year":"2023","journal-title":"Surv Ophthalmol"},{"issue":"9","key":"10.1016\/j.oret.2024.12.006_bib15","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1111\/dom.14445","article-title":"Risk of diabetic macular oedema with sodium-glucose cotransporter-2 inhibitors in type 2 diabetes patients: a multi-institutional cohort study in Taiwan","volume":"23","author":"Su","year":"2021","journal-title":"Diabetes Obes Metab"},{"issue":"13","key":"10.1016\/j.oret.2024.12.006_bib16","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1001\/archinternmed.2012.1938","article-title":"Association between thiazolidinedione treatment and risk of macular edema among patients with type 2 diabetes","volume":"172","author":"Idris","year":"2012","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1016\/j.oret.2024.12.006_bib17","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1001\/archophthalmol.2009.310","article-title":"Lack of association between thiazolidinediones and macular edema in type 2 diabetes: the ACCORD eye substudy","volume":"128","author":"Ambrosius","year":"2010","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"10.1016\/j.oret.2024.12.006_bib18","doi-asserted-by":"crossref","first-page":"e520","DOI":"10.1111\/aos.15778","article-title":"Development of diabetic macular oedema shows associations with systemic medication\u2014an epidemiological study","volume":"102","author":"Loukovaara","year":"2024","journal-title":"Acta Ophthalmol"},{"issue":"9600","key":"10.1016\/j.oret.2024.12.006_bib19","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0140-6736(07)61607-9","article-title":"Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial","volume":"370","author":"Keech","year":"2007","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.oret.2024.12.006_bib20","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1001\/jamaophthalmol.2014.2854","article-title":"Prevalence of and risk factors for diabetic macular edema in the United States","volume":"132","author":"Varma","year":"2014","journal-title":"JAMA Ophthalmol"},{"issue":"6","key":"10.1016\/j.oret.2024.12.006_bib21","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.jdiacomp.2017.02.018","article-title":"Diabetes complications severity index (DCSI)\u2014update and ICD-10 translation","volume":"31","author":"Glasheen","year":"2017","journal-title":"J Diabetes Complications"},{"issue":"7","key":"10.1016\/j.oret.2024.12.006_bib22","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1097\/HJH.0b013e3283472643","article-title":"Peripheral edema associated with calcium channel blockers: incidence and withdrawal rate-a meta-analysis of randomized trials","volume":"29","author":"Makani","year":"2011","journal-title":"J Hypertens"},{"issue":"4","key":"10.1016\/j.oret.2024.12.006_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0284364","article-title":"L-type calcium channel blocker increases VEGF concentrations in retinal cells and human serum","volume":"18","author":"Kumar","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.oret.2024.12.006_bib24","article-title":"FDA Approves First Treatment to Reduce the Risk of Serious Heart Problems in Specifically Adults with Obesity or Overweight. Silver Spring, MA","year":"2024","journal-title":"US Food and Drug Administration"},{"issue":"10","key":"10.1016\/j.oret.2024.12.006_bib25","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.jacbts.2023.05.012","article-title":"The cardioprotective effects of semaglutide exceed those of dietary weight loss in mice with HFpEF","volume":"8","author":"Withaar","year":"2023","journal-title":"JACC Basic Transl Sci"},{"issue":"12","key":"10.1016\/j.oret.2024.12.006_bib26","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1016\/j.ophtha.2014.07.019","article-title":"The effects of medical management on the progression of diabetic retinopathy in persons with type 2 diabetes: the action to control cardiovascular risk in diabetes (ACCORD) eye study","volume":"121","author":"Chew","year":"2014","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.oret.2024.12.006_bib27","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/dom.13538","article-title":"Worsening of diabetic retinopathy with rapid improvement in systemic glucose control: a review","volume":"21","author":"Bain","year":"2019","journal-title":"Diabetes Obes Metab"}],"container-title":["Ophthalmology Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653024005827?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653024005827?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T07:48:47Z","timestamp":1748936927000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468653024005827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S2468653024005827"],"URL":"https:\/\/doi.org\/10.1016\/j.oret.2024.12.006","relation":{},"ISSN":["2468-6530"],"issn-type":[{"value":"2468-6530","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influence of Common Medications on Diabetic Macular Edema in Type 2 Diabetes Mellitus","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Retina","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oret.2024.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}